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A B S T R A C T
Basement membranes (BMs) are specialised extracellular matrices that provide structural support to tissues as
well as influence cell behaviour and signalling. Mutations in COL4A1/COL4A2, a major BM component, cause a
familial form of eye, kidney and cerebrovascular disease, including stroke, while common variants in these genes
are a risk factor for intracerebral haemorrhage in the general population. These phenotypes are associated with
matrix defects, due to mutant protein incorporation in the BM and/or its absence by endoplasmic reticulum (ER)
retention. However, the effects of these mutations on matrix stiffness, the contribution of the matrix to the
disease mechanism(s) and its effects on the biology of cells harbouring a collagen IV mutation remain poorly
understood. To shed light on this, we employed synthetic polymer biointerfaces, poly(ethyl acrylate) (PEA) and
poly(methyl acrylate) (PMA) coated with ECM proteins laminin or fibronectin (FN), to generate controlled
microenvironments and investigate their effects on the cellular phenotype of primary fibroblasts harbouring a
COL4A2+/G702D mutation. FN nanonetworks assembled on PEA induced increased deposition and assembly of
collagen IV in COL4A2+/G702D cells, which was associated with reduced ER size and enhanced levels of protein
chaperones such as BIP, suggesting increased protein folding capacity of the cell. FN nanonetworks on PEA also
partially rescued the reduced stiffness of the deposited matrix and cells, and enhanced cell adhesion through
increased actin-myosin contractility, effectively rescuing some of the cellular phenotypes associated with
COL4A1/4A2 mutations. The mechanism by which FN nanonetworks enhanced the cell phenotype involved
integrin β1-mediated signalling. Collectively, these results suggest that biomaterials and enhanced integrin
signalling via assembled FN are able to shape the matrix and cellular phenotype of the COL4A2+/G702D mutation
in patient-derived cells.
1. Introduction
Basement membranes (BMs) are specialised extracellular matrix
(ECM) structures that provide structural support to tissues as well as
influence cell behaviour and signalling [1–3]. Major components are
laminins, collagen IV, perlecan and nidogen [2,4]. The vertebrate
genome encodes six collagen IV alpha chains, α1(IV)-α6(IV), encoded
by the genes COL4A1-COL4A6 that generate three collagen IV net-
works, namely α1α1α2(IV), α3α4α5(IV) and α5α5α6(IV) [3,5].
Mutations in COL4A1 and COL4A2 result in a rare familial multi-
systemic disease encompassing vascular, eye, kidney and muscle defects
[3]. The COL4A1 cerebrovascular disease affects the small vessels of the
brain and can result in intracerebral haemorrhage, porencephaly (the
formation of a cerebral cavity due to intracerebral haemorrhage), and
white matter hyperintensities [6–11]. The vast majority of mutations
affect glycine residues of the collagen repeats which alter protein
structure [5,12–14]. Interestingly, common variants within these genes
have been identified as risk factors for intracerebral haemorrhage [10],
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myocardial infarct [15], coronary artery disease [16] and vascular
stiffness [17]. Thus, collagen IV is emerging as a major component for
vascular diseases [7,9,10,15–22]. For many of these diseases, there is
an urgent need for novel treatments, which will require a more detailed
understanding of the underlying molecular mechanisms.
COL4A1/4A2 mutations such as the COL4A2+/G702D mutation, a
classical glycine mutation that substitutes a glycine residue for aspartic
acid [8], result in matrix defects in patients and mouse models, possibly
due to reduced levels of collagen IV caused by intracellular retention in
the endoplasmic reticulum (ER) [8,14,23–26]. The ER is the site where
three alpha chains interact to form a triple-helical collagen IV protomer
which after secretion generates a collagen IV network in the matrix. ER
retention of mutant protein can cause ER stress, which can activate the
unfolded protein response (UPR), a homeostatic response that can be-
come pathogenic when chronic [24]. Whereas the pathogenic me-
chanisms of collagen IV mutations remain unclear, a combination of
matrix defects and ER stress likely contribute to pathogenesis.
Recent data indicate that at least some of the cellular and mouse
phenotypes due to COL4A1/4A2 mutations can be modulated.
Targeting ER stress using the FDA-approved chemical chaperone phenyl
butyric acid (PBA) decreased intracellular collagen IV retention and ER
stress, and increased collagen IV secretion and deposition in the BM in
mice; this was associated with reduced cerebrovascular disease
[8,27–29]. However, PBA did not ameliorate the renal defects [27],
with recent evidence from mouse models supporting cell and/or tissue-
specific disease mechanisms whereby the contribution of ER stress and
matrix defects to disease may differ [13]. This has led to the suggestion
that the matrix defects also need to be targeted in order to develop
treatments that address the phenotypes in different tissues [27]. How-
ever, the effects of COL4A1/4A2 mutations on BM function and char-
acteristics remain poorly understood and, importantly, the effects of the
matrix on the behaviour and cellular phenotype of COL4A1/4A2 mu-
tant cells remain unknown. Addressing these gaps in our knowledge
could identify potential therapeutic targets and/or approaches.
Matrix composition, surface topography and the physical properties
of the substrate influence the behaviour of cells, and engineered bio-
materials provide a powerful approach to modulate the microenviron-
ment of cells and investigate their behaviour and function in response
to this altered environment [30]. In tissues, the ECM is a critical part of
the cell environment, and fibronectin (FN) is a major ECM component
that binds other matrix proteins, growth factors and cell surface re-
ceptors such as integrins, which are also collagen receptors. The bio-
logical activity of FN can be controlled by adsorbing it onto polymers
with defined chemistry, such as poly(ethyl acrylate) (PEA) and poly
(methyl acrylate) (PMA). Adsorption onto PEA results in physiological-
like FN nanonetworks that provide better availability of cell and growth
factors binding regions, while PMA leads to the formation of globular
aggregates (Fig. 1) [31–36]. The ability to adsorb matrix components
onto PEA and PMA therefore provides a powerful system to present the
cell with controlled distribution and conformation of matrix proteins.
For FN, the physical and chemical similarity of PEA and PMA provides a
robust system to investigate the effect of the FN network as a model of
an altered ECM on cells expressing mutant collagen IV [36].
Here, we have uncovered that FN nanonetworks assembled on PEA
promote the deposition of collagen IV in primary patient cells carrying
a COL4A2+/G702D mutation. This is associated with an increase in the
protein folding capacity of the cell, ameliorated stiffness of the cells and
their matrix, and increased cell attachment through focal adhesions. We
show that these effects are mediated by FN via specific integrin-medi-
ated signalling. These data indicate that biomaterials can offer a con-
trolled matrix to modulate the cellular phenotype of collagen IV mu-
tations.
2. Materials and methods
2.1. Preparation of polymer surfaces and protein adsorption
PEA and PMA polymers were synthesized by radical polymerization
of ethyl acrylate and methyl acrylate (Sigma, St. Louis, MO), initiated
by benzoin at 1 wt% and 0.35 wt%, respectively. PEA and PMA were
then dried by vacuum extraction to constant weight and solubilized in
toluene 2.5% w/v and 6% w/v respectively. PEA and PMA films
(~1 μm) were obtained by spin-casting polymer solutions on glass
coverslips (12 or 25 mm) at 2000 (PEA) and 3000 (PMA) rpm for 30 s,
with an acceleration of 3000 rpm/s. Samples were dried in vacuum for
2 h at 60 °C to remove excess toluene. Polymer surfaces were coated
with either natural mouse laminin 111 (LM; Invitrogen) or human
plasma FN (Sigma) solutions, in Dulbecco's phosphate-buffered saline
(DPBS) at concentrations 2, 10, 20, 50, and 100 μg/mL for 1 h and then
rinsed with DPBS before use. Mouse plasma fibronectins carrying mu-
tations in the FNIII10 module were also used. ΔRGD FN (FN without the
RGD sequence) and syn FN (FN with a mutation in the synergy se-
quence DRVPPSRN > DAVPPSAN) were generated and purified as
previously reported [37,38]. The amount of adsorbed protein was cal-
culated via depletion assay using the bicinchoninic acid working re-
agent (Thermo Fisher Scientific, Waltham, MA) as previously reported
[36].
2.2. Cell culture
Primary dermal fibroblast harbouring COL4A2+G702D mutation
(MT) [8] and wild type (WT) fibroblast cells (Tissue Culture Solutions
Cell Works, UK) were cultured in DMEM supplemented with 1% Glu-
tamax (Invitrogen™), 1% penicillin and streptomycin solution (Gibco®)
(final concentrations of 100 μg/mL), and 10% fetal bovine serum (FBS,
Invitrogen™) and kept in an incubator at 37 °C with 5% CO2. L-ascorbic
acid 2-phosphate sesquimagnesium salt hydrate (0.25 mM; Sigma) was
administered before cells were fixed to standardise collagen expression
and post-translational modifications [8].
2.3. Cell adhesion strength measurements
Cell adhesion strength to adsorbed FN on the polymer surfaces was
measured using a spinning disk device [39]. Substrates (25 mm cov-
erslips) were incubated with 2 or 20 μg/mL human FN for 30 min at RT
and then incubated with 1% BSA for 30 min at RT. Cells (10,000 cells/
cm2) were seeded onto substrates and allowed to uniformly attach for
several hours (as indicated in figure captions) in media with/without
serum in the incubator. Some substrates were treated with 10 μM
blebbistatin (B0560, Sigma-Aldrich) (inhibitor of myosin II). Samples
were mounted on the spinning disk device, the chamber apparatus was
filled with DPBS with 2 mM glucose, and the disk was spun for 5 min at
a constant speed with controlled acceleration rates at RT. After spin-
ning, cells were immediately fixed in 3.7% PFA, permeabilized with 1%
Triton X-100, and stained with ethidium homodimer (Molecular
Probes, Eugene, OR, USA), a DNA-specific fluorescent probe. Cells were
counted automatically at specific radial positions using a Nikon TE300
equipped with a Ludl motorized stage, Spot-RT camera, and Image-Pro
analysis system, at × 10 magnification.
Sixty-one fields (80–100 cells/field before spinning) were analysed
and cell counts were normalised to the number of cells present at the
centre of the disk, where negligible force is applied. The applied fluid
shear stress is given by the formula: =τ r ρμω0.8 ( )3 12 , where r is the
radial position from the centre of the coverslip, and ρ, μ, and ω are the
fluid density, viscosity, and rotational speed, respectively.
The fraction of adherent cells (f) was then fitted to a sigmoid curve,
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where b is the inflection slope, and τ50 is defined as the shear stress for
50% cell detachment and characterizes the mean adhesion strength of
the cell population. The experiment was performed with over eight
coverslips per condition and repeated at least twice.
2.4. Immunofluorescence staining
Cells were seeded (5000 cells/cm2) onto PEA and PMA (sterilised
under UV for 20 min) coated for 1 h with either wild type or mutant FN
(2, 20 μg/mL) or LM (20 μg/mL) and incubated for 2 h in serum-free
medium at 37 °C, 5% CO2, after which the medium was replaced with
medium with 10% FBS and 0.25 mM ascorbic acid. Incubation with
blebbistatin was performed (if appropriate) and cells fixed with PFA
3.7% for 20 min after specified times (1 and 7 days for matrix secre-
tion), washed 3x with DPBS, permeabilised (0.5% Triton X-100, 10.3%
saccharose, 0.292% NaCl, 0.06% MgCl2, and 0.48% HEPES adjusted to
pH 7.2) for 5 min and blocked in blocking buffer (BB, 1% Bovine serum
albumin, BSA, in DPBS) for 30 min. Cells were incubated with primary
antibodies in BB for 1 h at RT: monoclonal mouse anti-Col4a2
(Millipore, Cat. No. MAB1910), polyclonal rabbit anti-LM (Sigma, Cat.
No. L9393), polyclonal rabbit anti-PDI (Stressgen), polyclonal rabbit
anti-FN antibodies, rat anti-mouse CD29 integrin β1 (BD Biosciences),
human integrin alpha V/CD51 antibody (R&D Systems), mouse vinculin
hVIN-1 (Sigma-Aldrich, St. Louis, MO) or polyclonal rabbit paxillin
(Thermo Fisher Scientific, Waltham, MA). Cells were washed 3x DPBS/
Tween 20 (0.5% w/v), then incubated for 1 h with secondary anti-
bodies. These included Cy3 AffiniPure goat anti-rabbit (Cat. No. 111-
165-003, Jackson ImmunoResearch Laboratories Inc), Cy3 AffiniPure
goat anti-mouse IgG (Cat. No. 115-165-062, Jackson ImmunoResearch
Laboratories Inc), donkey anti-goat Alexa Fluor 568, anti-rat Alexa
Fluor 488, anti-mouse Alexa Fluor 488, anti-rabbit Alexa Fluor 647
(Thermo Fisher Scientific) (in BB). Actin staining was performed using
BODIPY FL phalloidin, Alexa Fluor® 350 Phalloidin or Rhodamine-
Phalloidin (Thermo Fisher Scientific). Samples were washed 3x, then
mounted with Vectashield with DAPI (Vector Laboratories) to stain the
nuclei and visualised using an epifluorescence microscope. Images were
taken and channels merged using ImageJ (1.47v).
Fractal dimension analysis of stained secreted collagen IV was car-
ried out using the ImageJ Fractal box count analysis tool, using box
sizes of 2, 3, 4, 6, 8, 12, 16, 32, and 64 pixels after thresholding and
binarization (Supplementary Fig. 1). Quantification of integrated den-
sity was done using ImageJ; the integrated density of each picture was
normalised using the number of cells (counted using DAPI) to obtain
the integrated density per cell.
Focal adhesions were quantified using the focal adhesion analysis
server [40]. Focal complexes, dot-like complexes shorter than 1 μm,
were discarded from the analysis [41]. Only isolated cells were used to
avoid altered area and roundness values that overlapping cells would
have produced. Images were analysed with ImageJ coupled with an in-
house macro processor, and the values of each condition were com-
pared.
2.5. Western blotting
Western blotting was performed as previously reported [26]. Pro-
tein extracts were prepared using RIPA buffer containing EDTA pro-
tease (Roche Applied Science) and phosphatase inhibitors (Phostop
Roche). Membranes were blocked with 5% milk before incubation with
primary antibodies calnexin (1/1000, Cell Signalling Technology), BIP
(1/40000, BD Transduction), DDR1 (C-20, sc-532, dilution 1:100),
polyclonal mouse anti FAK (1:2500 Upstate), and polyclonal rabbit anti
p-FAK (Tyr 397) (Merck Millipore). Secondary antibodies used were
anti-mouse (1:15000) or anti-rabbit (1:15000) fluorescently tagged
antibodies diluted in 50% TBS-T (0.1%) and 50% Seablock with 0.01%
SDS; for HRP-conjugated antibodies: donkey monoclonal anti-mouse
(1:10000) and donkey monoclonal anti-rabbit antibody (1:10000, GE
Healthcare) diluted in 2% BSA-TBST. Protein levels were corrected for
Coomassie staining of total protein gels ran in parallel with the western
blot gels, and measured using ImageJ software analysis. For analysis of
collagen IV secretion, culture medium was switched to serum starved
DMEM containing Ascorbic Acid 24 h before medium and cell collec-
tion. Conditioned media was collected and cell lysate were collected
following trypsinisation after which protein homogenates were pre-
pared in RIPA buffer. Primary antibody used was rat anti-COL4A2 H22
(1:75) from Dr. Tomono Yasuko (Shigei Medical Research Institute) and
rabbit anti-GAPDH (1:2000) (Sigma). Statistical analysis was performed
on a minimum of three independent experiments using the unpaired t-
test.
2.6. Atomic force microscopy
Atomic force microscopy (AFM) imaging was performed using a JPK
Nanowizard® 3 BioScience AFM (JPK Instruments, Berlin, Germany).
For imaging of FN adsorbed onto PEA or PMA, samples were rinsed in
water, dried gently with a nitrogen flow and imaged in tapping mode
using a cantilever with a resonance frequency ~75 kHz, a spring con-
stant of ~3 N/m, and a tip radius below 10 nm (Bruker). The AFM
images were 256 × 256 pixels unless specified. Height, phase and
Fig. 1. Molecular organisation of FN after ad-
sorption on PEA and PMA polymer substrates. (A)
Structure of PEA and PMA, and amount of adsorbed
FN from a solution concentration of 20 μg/mL for
1 h. (B) Immunostaining of FN. Insert: high magni-
fication images. Scale bars: 50 μm. (C) AFM height
images of FN. Scale bar: 250 nm.
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amplitude magnitudes were recorded simultaneously for each image.
For imaging and force spectroscopy measurements of cells and their
secreted matrix, cells were cultured on FN-interfaces for 7 days. All
measurements were then taken in liquid (DPBS or CO2 independent
media) at 37 °C. Stiffness of cells and matrix was measured in force
mapping mode using a tipless cantilever (Arrow TL1, k = ~0.03 N/m,
NanoWorld, Neuchâtel, Switzerland) mounted with a 4.83 μm diameter
silica bead (previously incubated in 1% BSA for 30 min to minimize
adhesion). Measurements were performed by indenting living cells on
top their nucleus in CO2 independent media. Force spectroscopy curves
were obtained, after calibration of cantilever sensitivity and spring
constant, with a set-point of 5 nN, a z-length of 5 μm, and a constant
duration of 1 s. Analyses were performed using the JPK data processing
software (v4.3.21) by fitting the force curves with a Hertz model at
500 nm indentation to obtain the Young's modulus [42,43]. The stiff-
ness of the ECMs secreted by the cells on the surfaces was also measured
via AFM, using the quantitative imaging (QI) mode. To do so, the
samples were decellularised to obtain intact matrix deposited by cells
via treatment with 20 mM ammonium hydroxide (NH4OH) 0.5% (w/v)
in warm water until all the cells debris was removed except the in-
soluble ECMs. The ECMs were then scanned using a pyramidal canti-
lever (PNP-DB-20, k = ~0.4 N/m, NanoWorld, Neuchâtel, Switzer-
land). The analysis was performed using the JPK data processing
software (v4.3.21) by fitting the force curves with a Hertz model at
50 nm indentation to obtain the Young's modulus map alongside the
contact point height image of the secreted protein matrices. The ECMs
were also stained with DAPI to confirm whether the cells were suc-
cessfully removed.
2.7. Electron microscopy analysis
Cells were cultured on FN-coated PMA and PEA for 7 days and fixed
in 2% glutaraldehyde prepared in 100 mM phosphate buffer (pH 7.0).
Further processing was performed as previously described [44].
2.8. Statistical analysis
All images were analysed using ImageJ software (v1.48). The data
were statistically analysed using GraphPad Prism 6 (GraphPad soft-
ware, La Jolla, CA). Where relevant, one-way or two-way ANOVA tests
were performed using a Bonferroni or Tukey post-hoc test to compare
all columns, and the differences between groups were considered sig-
nificant for *p≤ 0.05, **p≤ 0.01, ***p≤ 0.001, and ****p≤ 0.0001.
Error bars represent a standard deviation.
3. Results
3.1. Col4 deposition and ER-stress of COL4A2+/G702D fibroblasts
COL4A2+/G702D fibroblasts (mutant, MT) were cultured on fi-
bronectin (FN)-coated substrates, which control the organisation and
presentation of adsorbed FN, and on glass controls (uncoated).
Adsorbed FN assembled into physiological-like nanonetworks on PEA,
whilst it retained a globular conformation on PMA, with similar
amounts of adsorbed FN (Fig. 1). To investigate the effects of the
controlled matrix on the behaviour of COL4A2 mutant cells, we as-
sessed COL4A2 deposition. Image analysis revealed reduced COL4A2
deposition on glass after 1 and 7 days (Fig. 2A, B and C) in MT cells
compared to WT, as previously reported [8,45]. To provide the first
insight into the secreted collagen IV network of COL4A1 or COL4A2
mutant cells, we also assessed the fractal dimension of the collagen IV
network as a descriptor of its interconnected fibrillar organisation
(Fig. 2E). The collagen IV network of COL4A2+/G702D fibroblasts on
glass is characterised by reduced fractal dimension and a disrupted fi-
brillar organisation; this confirms the “structural” effect of the glycine
mutations on the collagen IV network. This was accompanied by a
slower growth rate for the MT cells [6], which were less confluent, with
cell size often enlarged and formation of patchy populations indicative
of cell death compared to WT cells (Supplementary Fig. 2).
Strikingly, we observed that MT fibroblasts on FN-coated polymers
displayed increased deposition of secreted collagen IV, especially after
7 days of culture (Fig. 2C). This was particularly significant for cells on
the FN nanonetworks on PEA, where collagen IV deposition by MT cells
was the highest and the fractal feature of the collagen meshwork was
recovered (Fig. 2E). This enhanced deposition on FN-coated PEA
compared to FN-coated PMA (where FN remains globular) and glass
was confirmed by in-cell-western (Supplementary Figs. 3A–B), ELISA
(Supplementary Fig. 3C) and fluorescent staining without cell per-
meabilization to avoid detecting intracellular proteins (Supplementary
Fig. 4). Increased matrix deposition was also apparent in electron mi-
croscopy images, which showed enhanced fibrillar matrix deposition in
MT cells on PEA compared to PMA (Supplementary Fig. 5). Moreover,
this response appeared specific for FN-coated PEA, as LM-coated sam-
ples did not yield the same effect (Supplementary Fig. 6). The increased
deposition did not extend to other major BM components as LM protein
levels decreased on FN-coated polymers (Fig. 2D), and was independent
of increased bulk secretion (Supplementary Fig. 7).
We next investigated whether the higher collagen IV levels on FN-
coated PEA were accompanied by a reduction in intracellular collagen
IV retention. Co-staining was performed with protein disulphide iso-
merase (PDI), a marker of the endoplasmic reticulum (ER), as ER stress
is associated with an increase in ER size and area of the cells [8]. This
revealed significantly lower levels for MT cells on PEA-FN compared to
MT cells on glass and PMA-FN, suggesting a decrease in ER area in MT
cells on FN-coated PEA (Fig. 3A and B). Swollen vesicles were also more
apparent by electron microscopy in cells cultured on PMA compared to
PEA (Supplementary Fig. 5).
The protein folding capacity of the cells is determined by the levels
and activities of the protein folding machinery including chaperones
such as BIP; for example, levels of BIP are associated with levels of
protein secretion in yeast [46]. To investigate whether the decrease in
ER area in the MT cells on FN-coated PEA was associated with increased
protein folding capacity, the protein levels of chaperones BIP and cal-
nexin were measured by western blot (Fig. 3C-D). Interestingly, this
revealed elevated BIP protein levels in both cell lines when grown on
PEA-FN compared to PMA, indicating a mutation-independent effect.
This suggests that PEA-FN may lead to an increase in the protein folding
capacity of the cells.
3.2. Elastic properties of COL4A2+/G702D fibroblasts and of their ECM
The characteristics of the extracellular matrix influence the beha-
viour and function of various cell types, including vascular cells [47].
However, the effect of any collagen IV mutation on the characteristics
of the basement membrane remains unclear. To address this, the effect
of the COL4A2+/G702D mutation on the biomechanical properties of the
cells and their matrix was analysed via atomic force microscopy (AFM)
by measuring the overall stiffness of matrix and cells, and then of the
decellularised ECM only. The Young's modulus of the MT cells, mea-
sured via nano-indentation using beaded cantilevers, was 10-fold lower
than that of WT cells after 7 days of culture on glass, PEA-FN or PMA-
FN (Fig. 4A). Values ranged mainly from 500 to 1000 Pa on glass, from
2000 to 5000 Pa on PEA-FN, and from 500 to 1500 Pa on PMA-FN for
WT cells (Supplementary Fig. 8A), and from 10 to 50 Pa on glass, from
100 to 350 Pa on PEA-FN, and from 25 to 150 Pa on PMA-FN for MT
cells (Supplementary Fig. 8B). In any case, culture on PEA-FN increased
the Young's modulus of cells and their matrix (Fig. 4A). Most interest-
ingly, the measurement of the elastic properties of the decellularized
matrix (Fig. 4B) using a pyramidal tip in quantitative imaging mode
revealed a partial recover of matrix stiffness when MT cells were cul-
tured on PEA. Indeed, the values on PEA-FN ranged from 7.5 to 18 kPa
for the MT-secreted matrix, and from 20 to 43 kPa for WT. On PMA-FN
E. Ngandu Mpoyi, et al. Biomaterials 252 (2020) 120090
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the values were instead generally lower than 10 kPa for both cell types.
These data suggest that the increased deposition by culture on PEA-FN
is able to partially rescue the mechanical properties of the secreted
ECM. Moreover, 3D reconstruction of the decellularised ECMs by MT
cells cultured on PEA-FN show a clear fibrillar organisation (Fig. 4C–D).
No measurements were made for ECMs secreted by cells on glass, as
they often detached from the substrate during the measurements.
3.3. Cell adhesion
To gain insight into underlying mechanisms of the altered stiffness
and behaviour of the MT cells when cultured on FN-coated PEA, we
analysed the early cell adhesion to the substrates, focusing on the de-
velopment of focal adhesion (FA) complexes and on the role of the
cytoskeleton. Focal adhesions were visualised using antibody staining
against paxillin (Fig. 5A–B). Image analysis revealed increased cell size
for MT cells compared to WT (Fig. 5C), and well-defined FA plaques for
both cell types, mainly located at the cell periphery (Fig. 5A–B). To
explore the role of contractility, cells were incubated with blebbistatin,
which inhibits myosin-II-specific ATPase activity. Treatment with
blebbistatin did not affect cell morphology, except a few cell protru-
sions of MT cells on PEA-FN and PMA-FN (Supplementary Figs. 9A–B).
To quantify the maturation level of the FAs on the different surfaces, FA
count and size (defined as the length of the major axis of the FA plaque)
were analysed (process detailed in Supplementary Fig. 10). The number
and size of FAs for MT cells were significantly higher on PEA-FN
compared to glass and PMA-FN (Fig. 5D and E), whilst no differences
were found for WT cells. Strikingly, treatment with blebbistatin only
affected the MT cells cultured on PEA-FN by reducing the number and
size of the FAs to the same levels as the other surfaces (Fig. 5D and E),
indicating myosin II-regulated adhesion [48]. It is also worth noting
that ligand availability, as defined by the concentration of the FN
coating solution, affected MT cell behaviour, in terms of cell size and FA
number only on PEA-FN whilst it had no effect for MT cells cultured on
PMA-FN (Supplementary Figs. 9D and E).
The increased size and number of FAs for MT cells on PEA-FN
correlated with higher adhesion strength, measured using a spinning
disk hydrodynamic shear assay (Fig. 5F) [39,49,50]. Detachment pro-
files (adherent fraction f versus shear stress τ) were fitted to a sigmoid
curve to obtain the shear stress for 50% detachment (τ50), which is
defined as the adhesion strength (Fig. 5G) [51]. MT cells showed sta-
tistically higher adhesion strength on PEA-FN compared to glass and
PMA-FN. This was reduced when contractility was inhibited using
blebbistatin (Fig. 5H), in accordance with FA analyses results (Fig. 5D
and E) and supporting the role for myosin II-regulated adhesion on
PEA-FN. Studies at increasing FN coating solution concentrations con-
firmed a direct relationship between ligand density and adhesion
strength, which increased for PEA-FN (Supplementary Fig. 9G)
[39,50,51]. The role of cell cytoskeleton in adhesion to PEA was also
confirmed via electron microscopy, which showed enhanced micro-
filament organisation within cells cultured on PEA-FN compared to
PMA-FN (Supplementary Fig. 5).
Considering that cell adhesion to FN is mainly mediated by α5β1 and
αVβ3 integrins [52], we explored their role in the stronger adhesion of
MT cells to the FN nanonetworks on PEA compared to PMA-FN or glass.
Both integrins were expressed by both cell types adhering on FN-coated
substrates (Fig. 5A–B and Supplementary Fig. 11). In particular, β1
staining showed well-pronounced clusters resembling FA contacts for
Fig. 2. Deposition of Col4A2 (green) and LM (red) by control (A) and mutant fibroblasts (B) on PEA and PMA coated with FN. Cells were grown on PEA and
PMA substrates-coated with FN 20 μg/ml and on glass for 2 h under serum free conditions; then with serum before fixation at different time points (1 and 7 days).
Cells were also simultaneously stained with DAPI (Blue). Scale bars: 50 μm (for all micrographs). Quantification of expressed Col4A2 (C) and LM (D) using integrated
density per cell. Fractal dimension analysis of secreted Col4A2 (E). Data presented as mean ± SD, N ≥ 10; and analysed with an ANOVA test; *p < 0.05;
***p < 0.001. Important statistical significance differences between the WT and the MT cells are indicated, including between the substrates for the MT. WT, wild
type control fibroblast cells; MT, COL4A2+/G702D mutant fibroblast cells. (For interpretation of the references to colour in this figure legend, the reader is referred to
the Web version of this article.)
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the WT cells on all the surfaces. In contrast, it was rather dispersed
throughout the MT cells (Fig. 5A–B), while αv showed a diffused
staining in the entire cell on all the substrates for both MT and WT cells
(Supplementary Figs. 11A–B). Quantification of integrin staining
showed that number, size and area of β1 integrin clusters were gen-
erally higher for MT and WT cells on PEA-FN than on PMA-FN and
glass. For αv, on the other hand, the expression levels by MT cells were
maintained independently of the substrates (Supplementary Fig. 11C).
Collectively, these results indicate higher β1 expression by MT cells on
PEA-FN, suggesting the involvement of the FN fibrillar network on PEA
in cell adhesion and signalling.
As myosin II is important for the FA recruitment of focal adhesion
kinase (FAK) [53], we explored the potential role of FAK via Western
Blotting and immunofluorescent staining. Well-developed Y397-pFAK
clusters were observed on FN-coated polymers, while poorly developed
clusters occurred on glass (Supplementary Fig. 12A). Western blotting
confirmed higher levels of pFAK for the MT cells on FN-coated sub-
strates compared to glass. The MT cells level of pFAK was elevated on
PEA-FN compared to the WT cells (Supplementary Figs. 12B–C), cor-
relating with the observations of the immunostaining. This revealed
enhanced FAK signalling on MT cells from FN networks on PEA; note
that previous studies have shown little difference for pFAK between
PEA-FN and PMA-FN [34,35].
Besides integrin receptors, the disk-shaped receptor tyrosine kinases
discoidin domain receptors (DDRs) [54] also bind collagen [55]. DDR1
is a tyrosine kinase transmembrane receptor that binds collagen IV and
other collagens and regulates cell adhesion, differentiation, migration
and proliferation [54,55]. As the effects of collagen IV mutations on
DDR1 expression are unknown, we performed immunostaining which
revealed DDR1 expression on the membrane surface for both cell types
on all surfaces (Supplementary Fig. 12D). Intriguingly, western blotting
detected higher DDR1 protein levels for the MT cells on glass compared
to the FN-coated substrates, and statistically higher than WT cells
(Supplementary Figs. 12E–F). This suggests an inverse correlation be-
tween DDR1 protein levels and amount of collagen IV deposition,
whereby reduced collagen deposition due to the COL4A2 mutation
leads to upregulation of DDR1.
To further corroborate the implication of integrin binding and cell
contractility in the change of the MT cell phenotype when cultured on
FN nanonetworks, COL4A2 deposition was assessed on PEA substrates
coated with mutated fibronectin molecules or in the presence of bleb-
bistatin. In particular, mouse ΔRGD FN (FN lacking the RGD motif) and
mouse syn FN (FN with a mutation on the DRVPPSRN synergy binding
site) were coated onto PEA, forming FN nanonetworks lacking the
ability to bind both α5β1 and αvβ3 (ΔRGD FN) or to reinforce binding to
α5β1 (syn FN), respectively (Supplementary Fig. 13A) [56,57]. Im-
munofluorescent staining confirmed that higher deposition and fibrillar
organisation of collagen IV by MT fibroblasts only occurred on PEA
coated with wild type FN, as both mutations reverted the rescue effect
of the wild type FN nanonetworks (Fig. 6). This suggests a major role
for α5β1 integrin. Interestingly, the unavailability of the cell binding
and of the synergy domain on the FN nanonetwork only affected the
behaviour of MT cells, whilst WT fibroblasts were unaffected
(Supplementary Fig. 13B). Moreover, the addition of blebbistatin to the
Fig. 3. Protein folding capacity of COL4A2+/G702D fibroblast cells. Staining of COL4A2 (green) and PDI (red) in WT (top row) and MT fibroblasts (bottom row),
also simultaneously stained with DAPI (Blue). Cells were cultured on FN-coated PEA and PMA substrates for 7 days. Scale bars: 50 μm (for all micrographs) (A).
Quantification of expressed PDI and Col4A2 integrated density measurements per cell, N = 12 (B). Western blot analysis of ER stress markers Calnexin (90 kDa) and
BIP (78 kDa) levels in cell lysates from WT and MT cells cultured for 7 day (C); Densitometry of western blots shown in arbitrary units (AU), N = 4 (D). Data
presented as mean ± SD; *p < 0.05, **p < 0.01, ***p < 0.001. WT, wild type; MT, COL4A2+/G702D fibroblasts. (For interpretation of the references to colour in
this figure legend, the reader is referred to the Web version of this article.)
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media during the culture also ablated MT cells collagen IV deposition
by inhibiting cell contractility (Fig. 6).
4. Discussion
It is known that material properties, such as stiffness, topography
and chemistry, can alter cell phenotype and drive cellular processes
such as cell migration, cell signalling and (stem) cell differentiation
[58–60]. These processes involve the secretion of new ECM at the cell-
material interface, whose composition and nature are modulated by the
properties of the biomaterials on which cells grow. Here, we demon-
strate that engineered biomaterials have the potential to modulate
matrix defects due to mutations in collagen IV in fibroblasts. The
COL4A2+/G702D mutation and other COL4A1/4A2 mutations result in
lower deposition and incorporation of collagen IV into the BM [8,45].
Our results show that FN nanonetworks assembled on the surface of
PEA increase the deposition of COL4A2 by COL4A2+/G702D mutant cells
to levels similar to WT (normal) cells. This phenomenon is shown via
several approaches: immunofluorescence (including without permea-
bilization, to rule out the possibility of staining intracellular COL4A2,
and after a decellularization assay), in-cell western and ELISA. We also
demonstrate reduced ER stress (reduced ER area – PDI) in MT cells
triggered by PEA-FN; this is accompanied by a likely increase in protein
folding capacity, with increased levels of molecular chaperone BIP
(Fig. 7).
MT cells do not increase COL4A2 deposition when cultured on LM
interfaces (PEA, PMA, glass) or interfaces where FN remains globular
(glass, PMA). The effect is specific to FN nanonetworks assembled on
PEA, which appear to enable a partial rescue of the retention and in-
tracellular accumulation of COL4A2 in MT cells.
Larger MT cells were found on PEA-FN, with higher FA count and
size compared to the cells cultured on PMA-FN or glass. Moreover,
these FAs contain higher density of β1 integrins, which are the main
receptor involved during the initial cell interaction with the material-
driven FN network and physiological FN matrices [34]. FN adsorption
on PEA unfolds the protein leading to the availability of domains that
promote FN-FN interactions, such as FNI1–5, enabling self-assembly into
fibrils, recapitulating aspects of cell-mediated FN fibrillogenesis
[35,36]. This material-driven FN matrix also favours enhanced ex-
posure of the integrin-binding region FNIII9-10 along with the growth
Fig. 4. Elastic modulus analysis of mutant cells and secreted ECMs. Young's modulus of WT and MT cells on the different substrates measured via AFM force
mapping; cells were cultured for 7 days and then indented with a cantilever mounted with a 4.83 μm silica bead (A). Young's modulus of ECMs obtained using the
Hertz model on at least 20 measurements (N≥ 20) taken from the points indicated by the yellow arrows in the AFM images C and D (B). AFM height images (first
column) and 3D reconstruction (second column) of ECMs after decellularization of WT (C) and MT (D) cells; cells were cultured on FN-coated PEA and PMA for 7
days and then decellularized using 20 mM ammonium hydroxide (NH4OH) solution, leaving the ECMs intact; then, AFM quantitative imaging was carried out in
DPBS using a pyramidal tip. The colour scale of the 3D reconstruction represents the local Young's modulus of the ECMs, calculated using the Hertz model. All data
are presented as mean ± SD, and analysed with an ANOVA test; **p < 0.01, ***p < 0.001, ****p < 0.0001. WT, wild type; MT, COL4A2+/G702D cells. (For
interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.)
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Fig. 5. Focal adhesion assembly, β1 integrin expression and cell adhesion strength measurements on FN-coated PEA and PMA substrates.
Immunofluorescence images of focal adhesions and β1 integrin of WT (A) and MT (B) fibroblast cells on glass, and on PEA and PMA coated with 20 μg/ml of FN. Cells
were cultured for 2 h in media under serum-free conditions, then fixed and stained for paxillin (red), β1 integrin (blue) and actin (green). Further images, including
cells treated with blebbistatin, are provided in supplementary data (Supplementary Fig. 9B). Size of WT and MT cells (C); number of FAs per cell (D); size of FAs (E).
Schematic of spinning disk assay (F). Characteristic detachment profile (G) showing fraction of adherent cells (f) as a function of surface shear stress (τ). Adhesion
strength measurements for WT and MT cells (H). Quantification of integrated β1 integrin cluster size (I), area (J) and count (K). Data presented as mean ± SD,
N ≥ 12 for images C–H and N ≥ 3 for images I–K, and analysed with an ANOVA test; *p < 0.05, **p < 0.01, ***p < 0.001. Important statistical significance
differences between the WT and the MT cells are indicated, including between the substrates for the MT. WT, wild type; MT, COL4A2+/G702D fibroblasts. (For
interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.)
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factor binding region FNIII12-14 [31,33,60]. Hence, FN assembled on
PEA is recognised by β1 integrins, as confirmed here in COL4A2+/G702D
fibroblasts on PEA-FN (Fig. 5). Higher expression of β1 has also been
previously correlated to α5β1 integrin-mediated adhesion to FN ma-
trices [51]. The role of β1 in rescuing the deposition of COL4A2 in MT
cells is demonstrated by the use of mutant fibronectins (Fig. 6). Binding
of α5β1 involves simultaneous availability of the synergy DRVPPSRN
and RGD sequences within FN [34]. FNs lacking the RGD peptide or the
synergy sequence are also assembled into nanonetworks on PEA
(Supplementary Fig. 13A), but they do not lead to enhanced matrix
deposition of COL4A2 in MT cells (Fig. 6) [33,36,61]. Interestingly, our
data are in agreement with recent in vivo data in C. elegans supporting
the role of integrin in promoting the incorporation of collagen IV into
basement membranes from secreted proteins, independently of actual
increase in collagen secretion [62]. Also, we show that the contractile
machinery of the cells (ROCK) is activated by binding of β1 integrins to
FN networks on PEA, as the use of blebbistatin reduces adhesion
strength only on PEA (Fig. 5H), and further ablates the rescue of
COL4A2 deposition (Fig. 6). This ability of FN-assembled on PEA to
trigger cell contractility has been previously demonstrated in cell
differentiation processes [35].
Mechanical properties, especially stiffness, of cells and their sur-
rounding ECM play important roles in many biological processes in-
cluding cell growth, motility, division, differentiation, tissue home-
ostasis, stem cell differentiation, tumour formation and wound healing
[63]. Changes in stiffness of live cells and ECM are often signs of
changes in cell physiology or diseases in tissues [64]. Stiffness analysis
via AFM showed that the MT cells and their ECMs were 10-fold softer
than the WT cells, directly indicating for the first time effects on matrix
stiffness due to collagen IV mutations (Fig. 4A). However, MT cells were
significantly stiffer on FN assembled on PEA, than on glass and FN-
coated PMA. Cell stiffness is related to the networks of F-actin and in-
termediate filaments inside the cells [39,49,65,66], which are generally
observed in a lower amount in the MT than in the WT cells, but not on
PEA-FN (Fig. 5 and Supplementary Fig. 5). In addition to this, the ECM
secreted by MT cells is also stiffer on PEA-FN (Fig. 4B), which can be
related to the higher amount of deposited COL4A2 on PEA-FN forming
interconnected fibrillar networks (Figs. 2 and 4D) [67]. It is also in-
teresting to note that variants in COL4A1, the obligatory protein partner
of COL4A2, are genetically associated with vascular stiffness [17].
Fig. 6. Deposition of COL4A2 by MT fibroblasts on FN nanonetworks is regulated by integrin binding and cell contractility. COL4A2 staining (green) of cells
grown on PEA substrates coated with either FN, FN without the RGD domain (ΔRGD FN), FN with a mutation on the synergy binding site (syn FN), or in the presence
of blebbistatin (BB) in the culture medium for 7 days; LM (red) and nuclei (blue) were also stained (A). Quantification of the integrated density of COL4A2 staining
after variance filtering (B). Controls are WT fibroblasts and MT fibroblasts cultured on glass. Data presented as mean ± SD, N≥ 12, and analysed with an ANOVA
test; *p < 0.05, **p < 0.01, ***p < 0.001. WT, wild type; MT, COL4A2+/G702D fibroblasts. (For interpretation of the references to colour in this figure legend, the
reader is referred to the Web version of this article.)
Fig. 7. Conceptual scheme. Illustration of the effect of the fibrillar FN nanonetworks on PEA, which induces increased deposition of Col4A2 by COL4A2+/G702D
mutant cells.
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While this study has used patient-derived fibroblasts, it could be
extended to other types of collagen IV-producing cells in relevant tis-
sues and organs. However, analysis into different cell types would in-
clude extensive genome editing; altering collagen IV levels, for example
by transfecting the expression construct driving the COL4A2 G702D
mutation, may cause other defects, hampering the analysis.
5. Conclusion
We show that biomaterials alter the behaviour of COL4A2+/G702D
mutant cells by overcoming some of the cellular and matrix defects
caused by the mutation. Indeed, physiological-like FN nanonetworks
assembled on a specific polymer chemistry (PEA) trigger contractility-
dependent strengthening of MT cell adhesion through enhanced re-
cruitment of β1 integrins, which lead to increased protein folding ca-
pacity, increased collagen IV deposition and partial rescue of the me-
chanical properties of the secret matrix. Collectively, our results suggest
that enhanced integrin signalling, controlled here via biomaterial en-
gineering, influences aspects of the matrix and cellular phenotype of the
COL4A2+/G702D mutation in primary patient cells. These data enhance
our understanding of the biological consequences (function/behaviour)
of COL4A2 mutations and highlight avenues for potential therapeutic
approaches, which are critical to developing personalized therapeutic
strategies for intracerebral haemorrhage and other pathologies due to
collagen IV mutations.
Author contributions
MSS, TVA and MCantini conceived the research, designed experi-
ments and analysed data. ENM, MCantini, YYS, LF and YL performed
the experiments. AJG and KK designed experiments and edited the
manuscript. MCostell provided mutant FNs and edited the manuscript.
ENM, MCantini, TVA and MSS wrote the manuscript.
Declaration of competing interest
The authors declare that they have no known competing financial
interests or personal relationships that could have appeared to influ-
ence the work reported in this paper.
Acknowledgements
We would like to thank Dr. Tomono Yasuko (Shigei Medical
Research Institute) for the H22 antibody. We thank Rachel Love for the
technical support. We would like to acknowledge Profs. Catheline
Vilain and Marc Abramowicz (University Libre de Bruxelles, Belgium)
for generating the patient fibroblast cell cultures, and thank the family
for participating in this study. This work was supported by EPSRC (EP/
P001114/1 and EP/F500424/1). MC acknowledges support from MRC
through MR/S005412/1. TVA from Kidney Research UK (RP19/2012)
and MRC (MR/R005567-1 ). AJG was supported by a US NIH grant
(R01 EB024322)..
Appendix A. Supplementary data
Supplementary data to this article can be found online at https://
doi.org/10.1016/j.biomaterials.2020.120090.
References
[1] V.S. LeBleu, B. Macdonald, R. Kalluri, Structure and function of basement mem-
branes, Exp. Biol. Med. 232 (2007) 1121–1129.
[2] R. Kalluri, Basement membranes: structure, assembly and role in tumour angio-
genesis, Nat. Rev. Canc. 3 (2003) 422–433.
[3] T. Van Agtmael, L. Bruckner-Tuderman, Basement membranes and human disease,
Cell Tissue Res. 339 (2010) 167–188.
[4] R. Timpl, M. Aumailley, Biochemistry of basement membranes, Adv. Nephrol.
Necker. Hosp. 18 (1989) 59–76.
[5] J. Khoshnoodi, V. Pedchenko, B.G. Hudson, Mammalian collagen IV, Microsc. Res.
Tech. 71 (2008) 357–370.
[6] G. Breedveld, I.F. de Coo, M.H. Lequin, W.F. Arts, P. Heutink, D.B. Gould, et al.,
Novel mutations in three families confirm a major role of COL4A1 in hereditary
porencephaly, J. Med. Genet. 43 (2006) 490–495.
[7] D.B. Gould, F.C. Phalan, G.J. Breedveld, S.E. van Mil, R.S. Smith, J.C. Schimenti,
et al., Mutations in Col4a1 cause perinatal cerebral hemorrhage and porencephaly,
Science (New York, NY) 308 (2005) 1167–1171.
[8] L.S. Murray, Y. Lu, A. Taggart, N. Van Regemorter, C. Vilain, M. Abramowicz, et al.,
Chemical chaperone treatment reduces intracellular accumulation of mutant col-
lagen IV and ameliorates the cellular phenotype of a COL4A2 mutation that causes
haemorrhagic stroke, Hum. Mol. Genet. 23 (2014) 283–292.
[9] K. Vahedi, S. Alamowitch, Clinical spectrum of type IV collagen (COL4A1) muta-
tions: a novel genetic multisystem disease, Curr. Opin. Neurol. 24 (2011) 63–68.
[10] K. Rannikmae, G. Davies, P.A. Thomson, S. Bevan, W.J. Devan, G.J. Falcone, et al.,
Common variation in COL4A1/COL4A2 is associated with sporadic cerebral small
vessel disease, Neurology 84 (2015) 918–926.
[11] M. Traylor, C.R. Zhang, P. Adib-Samii, W.J. Devan, O.E. Parsons, S. Lanfranconi,
et al., Genome-wide meta-analysis of cerebral white matter hyperintensities in
patients with stroke, Neurology 86 (2016) 146–153.
[12] M.E. Meuwissen, D.J. Halley, L.S. Smit, M.H. Lequin, J.M. Cobben, R. de Coo, et al.,
The expanding phenotype of COL4A1 and COL4A2 mutations: clinical data on 13
newly identified families and a review of the literature, Genet. Med. 17 (2015)
843–853.
[13] F.E. Jones, M.A. Bailey, L.S. Murray, Y. Lu, S. McNeilly, U. Schlotzer-Schrehardt,
et al., ER stress and basement membrane defects combine to cause glomerular and
tubular renal disease resulting from Col4a1 mutations in mice, Dis. Mod. Mech. 9
(2016) 165–176.
[14] T. Van Agtmael, U. Schlotzer-Schrehardt, L. McKie, D.G. Brownstein, A.W. Lee,
S.H. Cross, et al., Dominant mutations of Col4a1 result in basement membrane
defects which lead to anterior segment dysgenesis and glomerulopathy, Hum. Mol.
Genet. 14 (2005) 3161–3168.
[15] Y. Yamada, K. Kato, M. Oguri, T. Fujimaki, K. Yokoi, H. Matsuo, et al., Genetic risk
for myocardial infarction determined by polymorphisms of candidate genes in
Japanese individuals, J. Med. Genet. (2007).
[16] H. Schunkert, I.R. Konig, S. Kathiresan, M.P. Reilly, T.L. Assimes, H. Holm, et al.,
Large-scale association analysis identifies 13 new susceptibility loci for coronary
artery disease, Nat. Genet. 43 (2011) 333–338.
[17] K.V. Tarasov, S. Sanna, A. Scuteri, J.B. Strait, M. Orru, A. Parsa, et al., COL4A1 is
associated with arterial stiffness by genome-wide association scan, Circ Cardiovasc
Genet 2 (2009) 151–158.
[18] I. Sibon, I. Coupry, P. Menegon, J.P. Bouchet, P. Gorry, I. Burgelin, et al., COL4A1
mutation in Axenfeld-Rieger anomaly with leukoencephalopathy and stroke, Ann.
Neurol. 62 (2007) 177–184.
[19] M. Jeanne, D.B. Gould, Genotype-phenotype correlations in pathology caused by
collagen type IV alpha 1 and 2 mutations, Matrix Biol. : J. Int. Soc. Matrix Biol.
57–58 (2017) 29–44.
[20] E. Plaisier, O. Gribouval, S. Alamowitch, B. Mougenot, C. Prost, M.C. Verpont, et al.,
COL4A1 mutations and hereditary angiopathy, nephropathy, aneurysms, and
muscle cramps, N. Engl. J. Med. 357 (2007) 2687–2695.
[21] P. Chan, J. Stolz, S. Kohl, W.C. Chiang, J.H. Lin, Endoplasmic reticulum stress in
human photoreceptor diseases, Brain Res. 1648 (2016) 538–541.
[22] M. Wang, R.J. Kaufman, Protein misfolding in the endoplasmic reticulum as a
conduit to human disease, Nature 529 (2016) 326–335.
[23] D.S. Kuo, C. Labelle-Dumais, D.B. Gould, COL4A1 and COL4A2 mutations and
disease: insights into pathogenic mechanisms and potential therapeutic targets,
Hum. Mol. Genet. 21 (2012) R97–R110.
[24] J.F. Bateman, R.P. Boot-Handford, S.R. Lamande, Genetic diseases of connective
tissues: cellular and extracellular effects of ECM mutations, Nat. Rev. Genet. 10
(2009) 173–183.
[25] D.B. Gould, J.K. Marchant, O.V. Savinova, R.S. Smith, S.W. John, Col4a1 mutation
causes endoplasmic reticulum stress and genetically modifiable ocular dysgenesis,
Hum. Mol. Genet. 16 (2007) 798–807.
[26] T. Van Agtmael, M.A. Bailey, U. Schlotzer-Schrehardt, E. Craigie, I.J. Jackson,
D.G. Brownstein, et al., Col4a1 mutation in mice causes defects in vascular function
and low blood pressure associated with reduced red blood cell volume, Hum. Mol.
Genet. 19 (2010) 1119–1128.
[27] F.E. Jones, L.S. Murray, S. McNeilly, A. Dean, A. Aman, Y. Lu, et al., 4-Sodium
phenyl butyric acid has both efficacy and counter-indicative effects in the treatment
of Col4a1 disease, Hum. Mol. Genet. (2018).
[28] M. Jeanne, J. Jorgensen, D.B. Gould, Molecular and genetic analyses of collagen
type IV mutant mouse models of spontaneous intracerebral hemorrhage identify
mechanisms for stroke prevention, Circulation 131 (2015) 1555–1565.
[29] G. Hayashi, C. Labelle-Dumais, D.B. Gould, Use of sodium 4-phenylbutyrate to
define therapeutic parameters for reducing intracerebral hemorrhage and myo-
pathy in Col4a1 mutant mice, Dis Model Mech 11 (2018).
[30] Y.S. Jo, S.C. Rizzi, M. Ehrbar, F.E. Weber, J.A. Hubbell, M.P. Lutolf, Biomimetic
PEG hydrogels crosslinked with minimal plasmin-sensitive tri-amino acid peptides,
J. Biomed. Mater. Res. 93 (2010) 870–877.
[31] M. Cantini, C. González-García, V. Llopis-Hernández, M. Salmerón-Sánchez,
Material-driven fibronectin fibrillogenesis, in: J.L. Brash, W. Norde (Eds.), Proteins
at Interfaces III State of the Art Horbett T, American Chemical Society, Washington,
DC, 2012, pp. 471–496 2012.
[32] D. Gugutkov, C. Gonzalez-Garcia, J.C. Rodriguez Hernandez, G. Altankov,
M. Salmeron-Sanchez, Biological activity of the substrate-induced fibronectin
E. Ngandu Mpoyi, et al. Biomaterials 252 (2020) 120090
10
network: insight into the third dimension through electrospun fibers, Langmuir 25
(2009) 10893–10900.
[33] V. Llopis-Hernandez, M. Cantini, C. Gonzalez-Garcia, Z.A. Cheng, J. Yang,
P.M. Tsimbouri, et al., Material-driven fibronectin assembly for high-efficiency
presentation of growth factors, Sci. Adv. 2 (2016) e1600188.
[34] V. Llopis-Hernández, P. Rico, D. Moratal, G. Altankov, M. Salmerón-Sánchez, Role
of material-driven fibronectin fibrillogenesis in protein remodeling, BioResearch
Open Access 2 (2013) 364–373.
[35] M. Salmeron-Sanchez, P. Rico, D. Moratal, T.T. Lee, J.E. Schwarzbauer, A.J. Garcia,
Role of material-driven fibronectin fibrillogenesis in cell differentiation,
Biomaterials 32 (2011) 2099–2105.
[36] F.A. Vanterpool, M. Cantini, F.P. Seib, M. Salmeron-Sanchez, A material-based
platform to modulate fibronectin activity and focal adhesion assembly, BioResearch
Open Access 3 (2014) 286–296.
[37] P. Rico, A. Rodrigo-Navarro, M. de la Peña, V. Moulisová, M. Costell, M. Salmerón-
Sánchez, Simultaneous boron ion-channel/growth factor receptor activation for
enhanced vascularization, Adv. Biosyst. 3 (2019) 1800220.
[38] L. Zilberberg, V. Todorovic, B. Dabovic, M. Horiguchi, T. Couroussé, L.Y. Sakai,
et al., Specificity of latent TGF-β binding protein (LTBP) incorporation into matrix:
role of fibrillins and fibronectin, J. Cell. Physiol. 227 (2012) 3828–3836.
[39] A.J. Garcia, F. Huber, D. Boettiger, Force required to break alpha5beta1 integrin-
fibronectin bonds in intact adherent cells is sensitive to integrin activation state, J.
Biol. Chem. 273 (1998) 10988–10993.
[40] M.E. Berginski, S.M. Gomez, The Focal Adhesion Analysis Server: a web tool for
analyzing focal adhesion dynamics, F1000Research 2 (2013) 68.
[41] B. Geiger, A. Bershadsky, R. Pankov, K.M. Yamada, Transmembrane crosstalk be-
tween the extracellular matrix–cytoskeleton crosstalk, Nat. Rev. Mol. Cell Biol. 2
(2001) 793–805.
[42] Y.H. Chim, L.M. Mason, N. Rath, M.F. Olson, M. Tassieri, H. Yin, A one-step pro-
cedure to probe the viscoelastic properties of cells by Atomic Force Microscopy, Sci.
Rep. 8 (2018) 14462.
[43] G. McPhee, M.J. Dalby, M. Riehle, H. Yin, Can common adhesion molecules and
microtopography affect cellular elasticity? A combined atomic force microscopy
and optical study, Med. Biol. Eng. Comput. 48 (2010) 1043–1053.
[44] S.H. Taylor, S. Al-Youha, T. Van Agtmael, Y. Lu, J. Wong, D.A. McGrouther, et al.,
Tendon is covered by a basement membrane epithelium that is required for cell
retention and the prevention of adhesion formation, PloS One 6 (2011) e16337.
[45] M. Jeanne, C. Labelle-Dumais, J. Jorgensen, W.B. Kauffman, M. Mancini Grazia,
J. Favor, et al., COL4A2 mutations impair COL4A1 and COL4A2 secretion and cause
hemorrhagic stroke, Am. J. Hum. Genet. 90 (2012) 91–101.
[46] A.S. Robinson, J.A. Bockhaus, A.C. Voegler, K.D. Wittrup, Reduction of BiP levels
decreases heterologous protein secretion in Saccharomyces cerevisiae, J. Biol.
Chem. 271 (1996) 10017–10022.
[47] J.P. Stegemann, H. Hong, R.M. Nerem, Mechanical, biochemical, and extracellular
matrix effects on vascular smooth muscle cell phenotype, J. Appl. Physiol. 98
(1985) 2321–2327 2005.
[48] D.W. Zhou, T.T. Lee, S. Weng, J. Fu, A.J. Garcia, Effects of substrate stiffness and
actomyosin contractility on coupling between force transmission and vinculin-
paxillin recruitment at single focal adhesions, Mol. Biol. Cell 28 (2017) 1901–1911.
[49] N.D. Gallant, K.E. Michael, A.J. Garcia, Cell adhesion strengthening: contributions
of adhesive area, integrin binding, and focal adhesion assembly, Mol. Biol. Cell 16
(2005) 4329–4340.
[50] A.J. Garcia, Get a grip: integrins in cell-biomaterial interactions, Biomaterials 26
(2005) 7525–7529.
[51] A.J. Garcia, N.D. Gallant, Stick and grip: measurement systems and quantitative
analyses of integrin-mediated cell adhesion strength, Cell Biochem. Biophys. 39
(2003) 61–73.
[52] F. Schaffner, A.M. Ray, M. Dontenwill, Integrin α5β1, the fibronectin receptor, as a
pertinent therapeutic target in solid tumors, Cancers 5 (2013) 27–47.
[53] A.M. Pasapera, I.C. Schneider, E. Rericha, D.D. Schlaepfer, C.M. Waterman, Myosin
II activity regulates vinculin recruitment to focal adhesions through FAK-mediated
paxillin phosphorylation, J. Cell Biol. 188 (2010) 877–890.
[54] B. Leitinger, E. Hohenester, Mammalian collagen receptors, Matrix Biol. : J. Int. Soc.
Matrix Biol. 26 (2007) 146–155.
[55] W. Vogel, G.D. Gish, F. Alves, T. Pawson, The discoidin domain receptor tyrosine
kinases are activated by collagen, Mol. Cell 1 (1997) 13–23.
[56] M. Benito-Jardon, S. Klapproth, L.I. Gimeno, T. Petzold, M. Bharadwaj, D.J. Muller,
et al., The fibronectin synergy site re-enforces cell adhesion and mediates a cross-
talk between integrin classes, Elife 6 (2017).
[57] M. Leiss, K. Beckmann, A. Giros, M. Costell, R. Fassler, The role of integrin binding
sites in fibronectin matrix assembly in vivo, Curr. Opin. Cell Biol. 20 (2008)
502–507.
[58] M.J. Dalby, N. Gadegaard, R.O. Oreffo, Harnessing nanotopography and integrin-
matrix interactions to influence stem cell fate, Nat. Mater. 13 (2014) 558–569.
[59] A.D. Celiz, J.G. Smith, R. Langer, D.G. Anderson, D.A. Winkler, D.A. Barrett, et al.,
Materials for stem cell factories of the future, Nat. Mater. 13 (2014) 570–579.
[60] A. Cipitria, M. Salmeron-Sanchez, Mechanotransduction and growth factor signal-
ling to engineer cellular microenvironments, Adv Healthc Mater 6 (2017).
[61] G.C. Reilly, A.J. Engler, Intrinsic extracellular matrix properties regulate stem cell
differentiation, J. Biomech. 43 (2010) 55–62.
[62] R. Jayadev, Q. Chi, D.P. Keeley, E.L. Hastie, L.C. Kelley, D.R. Sherwood, α-Integrins
dictate distinct modes of type IV collagen recruitment to basement membranes, J.
Cell Biol. 218 (2019) 3098–3116.
[63] D.E. Discher, P. Janmey, Y.L. Wang, Tissue cells feel and respond to the stiffness of
their substrate, Science (New York, NY) 310 (2005) 1139–1143.
[64] G. Thomas, N.A. Burnham, T.A. Camesano, Q. Wen, Measuring the mechanical
properties of living cells using atomic force microscopy, JoVE : JoVE (2013).
[65] D.W. Dumbauld, H. Shin, N.D. Gallant, K.E. Michael, H. Radhakrishna, A.J. García,
Contractility modulates cell adhesion strengthening through focal adhesion kinase
and assembly of vinculin-containing focal adhesions, J. Cell. Physiol. 223 (2010)
746–756.
[66] N. Wang, I.M. Tolic-Norrelykke, J. Chen, S.M. Mijailovich, J.P. Butler, J.J. Fredberg,
et al., Cell prestress. I. Stiffness and prestress are closely associated in adherent
contractile cells, Am. J. Physiol. Cell Physiol. 282 (2002) C606–C616.
[67] A. Bruel, G. Ortoft, H. Oxlund, Inhibition of cross-links in collagen is associated with
reduced stiffness of the aorta in young rats, Atherosclerosis 140 (1998) 135–145.
E. Ngandu Mpoyi, et al. Biomaterials 252 (2020) 120090
11
